Financhill
Back

Edgewise Therapeutics Quote, Financials, Valuation and Earnings

Edgewise Therapeutics Price Quote

$28.34
+0.08 (+-3.93%)
(Updated: September 21, 2024 at 6:22 AM ET)

Edgewise Therapeutics Key Stats

Buy
90
Edgewise Therapeutics (EWTX) is a Buy

Day range:
$27.76 - $29.94
52-week range:
$5.12 - $30.00
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
5.19%

Volume:
3.6M
Avg. volume:
1.4M
1-year change:
355.81%
Market cap:
$2.7B
Revenue:
$0
EPS:
$-1.55

How Much Does Edgewise Therapeutics Make?

Data Unavailable

Is Edgewise Therapeutics Growing As A Company?

Data Unavailable

Edgewise Therapeutics Stock Price Performance

What Is Edgewise Therapeutics 52-Week High & Low?

Edgewise Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Edgewise Therapeutics?

Is Edgewise Therapeutics Cash Flow Positive?

  • What Is EWTX Cash Flow From Operations?
    Cash flow from operations (TTM) is -$103.6M
  • What Is Edgewise Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $295.8M
  • What Is Edgewise Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$180.5M

Edgewise Therapeutics Return On Invested Capital

Data Unavailable

Edgewise Therapeutics Earnings Date & Stock Price

Edgewise Therapeutics Competitors

Edgewise Therapeutics Dividend Yield

Edgewise Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 0.6%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 3
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 40.83
Upside from Last Price: 44.49%

Major Shareholders

  • How many EWTX shares are owned by institutional investors?
    144.1M EWTX shares are owned by institutional investors
  • How many EWTX shares are owned by insiders?
    139.8K EWTX shares are owned by insiders